ALKS vs KMB · P/E 14, rev $1.56B vs P/E 19, rev $20.06B
Alkermes Plc (ALKS) versus Kimberly-Clark Corporation (KMB) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Kimberly-Clark Corporation (KMB) is a household & personal products company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported KMB revenue for 2024-12-31 was $20.06B. Net income was $2.58B. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
Not investment advice. Open the ALKS and KMB stock pages for the full models.
Not investment advice.